REAL DATASET CASE · AGGREGATE EVIDENCE ONLY
From catalogue upload to documented quality review.
An antimicrobial catalogue passed through data-quality screening, descriptive analysis, reference comparisons and controlled QA resubmission.
RMA case evidence · Revised 15 October 2026
What the documented run showed
| Aggregate | Recorded result | Interpretation boundary |
|---|---|---|
| Catalogue records | 505 | Catalogue entries, not patients. |
| Missing cells | 2,598 | Not a validity score. Eligibility and field definitions matter. |
| Affected records | 9 | A review queue, not full external verification. |
| Potential duplicate groups | 0 in that automated screen | No guarantee for other versions or matching rules. |
What RMA documented
Download the aggregate findings and limitations
- Screened the uploaded catalogue and produced numerical descriptives and category frequencies.
- Retained original source values through documented review decisions.
- Documented reference comparisons and the reasons for decisions in the revised work.
- Resubmitted the revised candidate through a controlled QA handoff.
This page reports aggregate evidence supplied for this case. It does not expose the source workbook, drug-specific values, private case IDs, client information or reference extracts.
Limitations that stay with the evidence
The revision itself was not final QA or release authorisation. Original source provenance was not fully established. No clinical-use, dosing, treatment or patient-outcome conclusion is supported.
Publication/reuse rights for source-specific material have not been established for this public page. Only the instructed RMA-generated aggregate facts and workflow description appear here. Detailed source material stays private pending rights review.
What a researcher can learn
Screening finds questions; reviewers decide what a signal means. A missing-cell count needs field context. A clean duplicate screen applies only to its matching rules and input version. Reference comparison does not remove provenance limitations. QA resubmission and approved release remain separate states.
Prepare an evidence-pack brief →